ID   NPC/HK1
AC   CVCL_7084
SY   HK1; HK-1
DR   BTO; BTO_0004899
DR   EFO; EFO_0022551
DR   Cell_Model_Passport; SIDM01997
DR   Cosmic; 755503
DR   Cosmic; 923772
DR   Cosmic; 1017618
DR   Cosmic; 1300997
DR   Ubigene; YC-C095
DR   Wikidata; Q54930981
RX   PubMed=6259064;
RX   PubMed=12645650;
RX   PubMed=18196576;
CC   Population: Chinese.
CC   Virology: EBV-negative.
CC   Doubling time: 28 +- 2 hours (PubMed=6259064).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
ST   Source(s): PubMed=18196576
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 26
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
RX   PubMed=6259064; DOI=10.1002/ijc.2910260202;
RA   Huang D.P., Ho J.H.-C., Poon Y.-F., Chew E.-C., Saw D., Lui M., Li C.L.,
RA   Mak L.S., Lai S.H., Lau W.H.;
RT   "Establishment of a cell line (NPC/HK1) from a differentiated squamous
RT   carcinoma of the nasopharynx.";
RL   Int. J. Cancer 26:127-132(1980).
//
RX   PubMed=12645650; DOI=10.1016/S0165-4608(02)00657-X;
RA   Wong N., Hui A.B.-Y., Fan B.-L., Lo K.-W., Pang E., Leung S.-F.,
RA   Huang D.P., Johnson P.J.;
RT   "Molecular cytogenetic characterization of nasopharyngeal carcinoma
RT   cell lines and xenografts by comparative genomic hybridization and
RT   spectral karyotyping.";
RL   Cancer Genet. Cytogenet. 140:124-132(2003).
//
RX   PubMed=18196576; DOI=10.1002/ijc.23374;
RA   Chan S.Y.-Y., Choy K.-W., Tsao S.-W., Tao Q., Tang T., Chung G.T.-Y.,
RA   Lo K.-W.;
RT   "Authentication of nasopharyngeal carcinoma tumor lines.";
RL   Int. J. Cancer 122:2169-2171(2008).
//